Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Treatment for rhinitis undergoes further development in Australia

April 11, 1997

Norastemizole demonstrates high efficacy, safety and rapid onset of action in humans

April 10, 1997

New LTD4 antagonist from Fujisawa

April 10, 1997

Dual H1/PAF antagonists disclosed by British Biotech

April 10, 1997

Quinolone PDE IV/TNF inhibitors from Chiroscience

April 9, 1997

RPR's Tilade approved for pediatric use

April 8, 1997

Clinical comparison of cromolyn and furosemide in asthmatics

April 8, 1997

PDE IV and/or TNF production inhibitors from Pfizer

April 7, 1997

Leukotriene antagonists claimed by Menarini

April 7, 1997

Dual NK1/NK2 receptor antagonists from Rhone-Poulenc Rorer

April 7, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...